These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1096 related articles for article (PubMed ID: 17565727)
1. Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire. Piault E; Evans CJ; Espindle D; Kopp Z; Brubaker L; Abrams P Neurourol Urodyn; 2008; 27(3):179-90. PubMed ID: 17565727 [TBL] [Abstract][Full Text] [Related]
2. Psychometric validation of the overactive bladder satisfaction with treatment questionnaire (OAB-SAT-q). Margolis MK; Fox KM; Cerulli A; Ariely R; Kahler KH; Coyne KS Neurourol Urodyn; 2009; 28(5):416-22. PubMed ID: 19030182 [TBL] [Abstract][Full Text] [Related]
3. The psychometric validation of the OAB family impact measure (OAB-FIM). Coyne KS; Matza LS; Brewster-Jordan J; Thompson C; Bavendam T Neurourol Urodyn; 2010 Mar; 29(3):359-69. PubMed ID: 19274760 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive evaluation of bladder and urethral dysfunction symptoms: development and psychometric validation of the Urinary Symptom Profile (USP) questionnaire. Haab F; Richard F; Amarenco G; Coloby P; Arnould B; Benmedjahed K; Guillemin I; Grise P Urology; 2008 Apr; 71(4):646-56. PubMed ID: 18313122 [TBL] [Abstract][Full Text] [Related]
5. Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ). Matza LS; Thompson CL; Krasnow J; Brewster-Jordan J; Zyczynski T; Coyne KS Neurourol Urodyn; 2005; 24(3):215-25. PubMed ID: 15747340 [TBL] [Abstract][Full Text] [Related]
6. Symptom severity and patient perceptions in overactive bladder: how are they related? Homma Y; Gotoh M BJU Int; 2009 Oct; 104(7):968-72. PubMed ID: 19338560 [TBL] [Abstract][Full Text] [Related]
7. Reliability and validity of the Overactive Bladder Symptom Score in Spanish (OABSS-S). Weinberg AC; Brandeis GH; Bruyere J; Tsui JF; Weiss JP; Rutman MP; Blaivas JG Neurourol Urodyn; 2012 Jun; 31(5):664-8. PubMed ID: 22488591 [TBL] [Abstract][Full Text] [Related]
8. Psychometric evaluation of the medical outcomes study-sleep scale in persons with overactive bladder. Lau DT; Morlock RJ; Hill CD Clin Ther; 2006 Dec; 28(12):2119-32. PubMed ID: 17296468 [TBL] [Abstract][Full Text] [Related]
9. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence. Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704 [TBL] [Abstract][Full Text] [Related]
10. Validation of treatment benefit scale for assessing subjective outcomes in treatment of overactive bladder. Colman S; Chapple C; Nitti V; Haag-Molkenteller C; Hastedt C; Massow U Urology; 2008 Oct; 72(4):803-7. PubMed ID: 18722655 [TBL] [Abstract][Full Text] [Related]
11. [Validation of a self-administered functional evaluation questionnaire after surgical treatment of lumbar spine stenosis]. Guigui P; Rillardon L; Veil-Picard A; Blamoutier A; Heissler P; Benoist M; Deburge A Rev Chir Orthop Reparatrice Appar Mot; 2002 Oct; 88(6):601-12. PubMed ID: 12447130 [TBL] [Abstract][Full Text] [Related]
12. Patient satisfaction with the benefits of overactive bladder treatment: exploration of influencing factors and development of a satisfaction assessment instrument. Zinner N; Kobashi K; Koochaki P; Fix D; Egermark M Neurourol Urodyn; 2011 Jan; 30(1):62-8. PubMed ID: 20860020 [TBL] [Abstract][Full Text] [Related]
13. The responsiveness of the OAB-q among OAB patient subgroups. Coyne KS; Matza LS; Thompson C; Jumadilova Z; Bavendam T Neurourol Urodyn; 2007; 26(2):196-203. PubMed ID: 17016794 [TBL] [Abstract][Full Text] [Related]
14. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. Coyne KS; Sexton CC; Irwin DE; Kopp ZS; Kelleher CJ; Milsom I BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794 [TBL] [Abstract][Full Text] [Related]
15. Linguistic validation of the N-QOL (ICIQ), OAB-q (ICIQ), PPBC, OAB-S and ICIQ-MLUTSsex questionnaires in 16 languages. McKown S; Abraham L; Coyne K; Gawlicki M; Piault E; Vats V Int J Clin Pract; 2010 Nov; 64(12):1643-52. PubMed ID: 20722767 [TBL] [Abstract][Full Text] [Related]
16. Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine. Coyne KS; Elinoff V; Gordon DA; Deng DY; Brodsky M; Glasser DB; Jumadilova Z; Carlsson M Int J Clin Pract; 2008 Jun; 62(6):925-31. PubMed ID: 18479285 [TBL] [Abstract][Full Text] [Related]
17. Development and preliminary validation of the Menopause Symptoms Treatment Satisfaction Questionnaire (MS-TSQ). Hill CD; Fehnel SE; Bobula JD; Yu H; McLeod LD Menopause; 2007; 14(6):1047-55. PubMed ID: 17413838 [TBL] [Abstract][Full Text] [Related]
18. Use of the short form of King's Health Questionnaire to measure quality of life in patients with an overactive bladder. Homma Y; Uemura S BJU Int; 2004 May; 93(7):1009-13. PubMed ID: 15142153 [TBL] [Abstract][Full Text] [Related]
19. The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder. Coyne KS; Matza LS; Kopp Z; Abrams P Eur Urol; 2006 Jun; 49(6):1079-86. PubMed ID: 16460875 [TBL] [Abstract][Full Text] [Related]
20. Psychometric performance of the incontinence quality-of-life questionnaire among patients with overactive bladder and urinary incontinence. Patrick DL; Khalaf KM; Dmochowski R; Kowalski JW; Globe DR Clin Ther; 2013 Jun; 35(6):836-45. PubMed ID: 23747076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]